Related Experiment Video

Updated: Jun 25, 2026

Identification of MyoD Interactome Using Tandem Affinity Purification Coupled to Mass Spectrometry
14:47

Identification of MyoD Interactome Using Tandem Affinity Purification Coupled to Mass Spectrometry

Published on: May 17, 2016

Repressing the repressor: a new mode of MYC action in lymphomagenesis

Sandrine Sander1, Lars Bullinger, Thomas Wirth

  • 1Institute of Physiological Chemistry, University of Ulm, Ulm, Germany.

Cell Cycle (Georgetown, Tex.)
|February 7, 2009
PubMed

Insights

MYC oncogene activity drives cancer by altering gene expression. This study reveals MYC represses miR-26a, a microRNA that suppresses tumors by targeting EZH2, impacting lymphomagenesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • The MYC oncogene is frequently dysregulated in human cancers, promoting tumor development.
  • MYC influences gene expression not only by regulating protein-coding genes but also microRNAs (miRNAs).
  • Understanding MYC's role in tumorigenesis requires investigating its impact on miRNA expression.

Purpose of the Study:

  • To investigate the role of miRNAs in MYC-driven tumorigenesis.
  • To identify specific miRNAs regulated by MYC and their functional significance.
  • To elucidate the molecular mechanisms by which MYC and miRNAs contribute to lymphomagenesis.

Main Methods:

  • Utilized microarray technology to profile miRNA expression in MYC-expressing models.
  • Employed cell line and murine lymphoma models with conditional MYC expression.
  • Investigated the functional effects of miR-26a restoration and identified its direct targets.

Main Results:

  • MYC was found to repress specific miRNAs, including miR-26a, across various tumor types.
  • Restoring miR-26a expression in MYC-dependent cells inhibited proliferation and cell cycle progression.
  • EZH2 (Enhancer of Zeste Homolog 2), a key regulator of gene expression, was identified as a direct target of miR-26a.
  • MYC-mediated suppression of miR-26a and subsequent EZH2 upregulation were critical for lymphomagenesis.

Conclusions:

  • MYC oncogenesis involves a dual mechanism: direct gene regulation and indirect modulation via miRNA deregulation.
  • miR-26a acts as a tumor suppressor in MYC-driven lymphomas by targeting EZH2.
  • Targeting the MYC-miR-26a-EZH2 axis offers potential therapeutic strategies for MYC-driven cancers.

More Related Videos

Inducible and Reversible Dominant-negative (DN) Protein Inhibition08:35

Inducible and Reversible Dominant-negative (DN) Protein Inhibition

Published on: January 7, 2019

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers10:28

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers

Published on: September 20, 2018

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.